Free Trial
TSE:OGI

Organigram 5/14/2024 Earnings Report

Organigram logo
C$1.98 +0.04 (+2.06%)
As of 03:59 PM Eastern

Organigram EPS Results

Actual EPS
-C$0.16
Consensus EPS
-C$0.08
Beat/Miss
Missed by -C$0.08
One Year Ago EPS
N/A

Organigram Revenue Results

Actual Revenue
$37.63 million
Expected Revenue
$38.20 million
Beat/Miss
Missed by -$570.00 thousand
YoY Revenue Growth
N/A

Organigram Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Organigram Earnings Headlines

The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
See More Organigram Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Organigram? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Organigram and other key companies, straight to your email.

About Organigram

Organigram (TSE:OGI) Inc. is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.

View Organigram Profile

More Earnings Resources from MarketBeat